Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India

BACKGROUND: The objective of this study was to evaluate the safety of twice daily, intra-vaginal use of 0.5% PRO 2000 Gel for fourteen days in HIV un-infected women at lower as well as higher risk for HIV acquisition, in Pune, India. METHODS: Forty-two eligible volunteers (30 low-risk and 12 high-ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Smita, Joshi, Soma, Dutta, Beverly, Bell, Albert, Profy, JoAnn, Kuruc, Fang, Gai, Missy, Cianciola, Lydia, Soto-Torres, Anjali, Panchanadikar, Arun, Risbud, Sanjay, Mehendale, Steven J, Reynolds
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435917/
https://www.ncbi.nlm.nih.gov/pubmed/16504023
http://dx.doi.org/10.1186/1742-6405-3-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435917/
https://www.ncbi.nlm.nih.gov/pubmed/16504023
http://dx.doi.org/10.1186/1742-6405-3-4

Ejemplares similares